Total Payments
$9,222
2024 Payments
$2,010
Companies
29
Transactions
148
Medicare Patients
885
Medicare Billing
$82,131
Payment Breakdown by Category
Food & Beverage$5,047 (54.7%)
Consulting$4,000 (43.4%)
Education$175.44 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,047 | 142 | 54.7% |
| Consulting Fee | $4,000 | 3 | 43.4% |
| Education | $175.44 | 3 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $4,022 | 7 | $0 (2017) |
| PFIZER INC. | $598.24 | 10 | $0 (2024) |
| UCB, Inc. | $539.50 | 8 | $0 (2024) |
| Promius Pharma LLC | $467.64 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $373.85 | 15 | $0 (2024) |
| Dermavant Sciences, Inc. | $353.32 | 17 | $0 (2024) |
| Incyte Corporation | $254.15 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $242.59 | 9 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $231.82 | 2 | $0 (2017) |
| LEO Pharma Inc. | $211.42 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,010 | 90 | Incyte Corporation ($240.35) |
| 2023 | $385.32 | 11 | Dermavant Sciences, Inc. ($167.53) |
| 2022 | $258.23 | 3 | Ortho Dermatologics, a division of Bausch Health US, LLC ($145.64) |
| 2020 | $115.09 | 4 | Janssen Biotech, Inc. ($115.09) |
| 2019 | $467.87 | 5 | UCB, Inc. ($249.81) |
| 2018 | $764.88 | 11 | PFIZER INC. ($244.43) |
| 2017 | $5,221 | 24 | Allergan Inc. ($4,022) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.88 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $36.06 | General |
| Category: Immunology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Immunology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: Immunology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $37.32 | General |
| Category: Immunology | ||||||
| 10/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.36 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.71 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 281 | 651 | $109,708 | $27,371 |
| 2022 | 8 | 196 | 456 | $76,008 | $18,944 |
| 2021 | 8 | 204 | 386 | $73,646 | $20,408 |
| 2020 | 9 | 204 | 315 | $61,737 | $15,407 |
Total Patients
885
Total Services
1,808
Medicare Billing
$82,131
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 86 | $29,438 | $7,959 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 87 | $21,461 | $6,046 | 28.2% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 13 | 191 | $13,734 | $4,186 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 42 | 61 | $15,459 | $2,716 | 17.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $7,204 | $1,599 | 22.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 17 | 21 | $7,498 | $1,462 | 19.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 16 | $5,680 | $1,449 | 25.5% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 14 | 16 | $3,929 | $1,065 | 27.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 31 | 152 | $5,305 | $888.80 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 85 | $20,386 | $5,474 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 57 | $18,941 | $4,999 | 26.4% |
| 96900 | Application of ultraviolet light to skin | Office | 2022 | 14 | 121 | $8,454 | $2,574 | 30.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 27 | 39 | $9,626 | $1,569 | 16.3% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2022 | 11 | 17 | $5,906 | $1,300 | 22.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 14 | $4,830 | $1,262 | 26.1% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 14 | 18 | $4,295 | $1,181 | 27.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 20 | 105 | $3,570 | $586.57 | 16.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 64 | $20,672 | $6,397 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 69 | $16,070 | $5,023 | 31.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 30 | $6,390 | $2,019 | 31.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 33 | 41 | $9,840 | $1,940 | 19.7% |
| 11310 | Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 17 | 17 | $5,746 | $1,688 | 29.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 12 | 15 | $5,025 | $1,358 | 27.0% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2021 | 13 | 21 | $4,872 | $1,232 | 25.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 25 | 129 | $5,031 | $751.48 | 14.9% |
About Dr. Elan Newman, M.D
Dr. Elan Newman, M.D is a Dermatology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821297649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elan Newman, M.D has received a total of $9,222 in payments from pharmaceutical and medical device companies, with $2,010 received in 2024. These payments were reported across 148 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,047).
As a Medicare-enrolled provider, Newman has provided services to 885 Medicare beneficiaries, totaling 1,808 services with total Medicare billing of $82,131. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location San Diego, CA
- Active Since 07/12/2007
- Last Updated 05/27/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1821297649
Products in Payments
- ACZONE (Drug) $2,011
- EUCRISA (Drug) $470.97
- VTAMA (Drug) $353.32
- Cloderm Cream (Drug) $350.00
- TREMFYA (Drug) $303.90
- OPZELURA (Drug) $254.15
- Sotyktu (Drug) $242.59
- STELARA (Biological) $231.82
- Otezla (Drug) $224.20
- ADBRY (Biological) $211.42
- Cimzia (Drug) $211.07
- SILIQ (Drug) $205.06
- Bimzelx (Biological) $186.10
- RHOFADE (Drug) $181.92
- VALCHLOR MECHLORETHAMINE (Drug) $136.32
- EPIDUO FORTE (Drug) $116.37
- Trianex (Drug) $112.64
- DUPIXENT (Drug) $105.17
- DUPIXENT (Biological) $103.14
- SKYRIZI (Biological) $98.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Diego
Dr. Sabrina Fabi, M.d, M.D
Dermatology — Payments: $3.3M
Dermatology $3.3M
Neal Bhatia, Md, MD
Dermatology — Payments: $2.6M
Dermatology $2.6M
Dr. Arisa Ortiz, M.d, M.D
Dermatology — Payments: $354,946
Dermatology $354,946
Dr. Dawn Eichenfield, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $179,796
Dermatology $179,796
Michael Bradshaw, M.d, M.D
Dermatology — Payments: $174,743
Dermatology $174,743
Dr. Tissa Hata, M.d, M.D
Dermatology — Payments: $138,047
Dermatology $138,047